Enter assignee name

EPO Patents = 2

Forward Citations = 2

Loading Chart...

27 inventors (with patents filed for the assignee):

Tatsuhiko Kodama (4 out of 30 patents)

Motomu Kanai (4 out of 21 patents)

Akira Sugiyama (4 out of 79 patents)

4. Tsuyoshi Inoue (4 out of 94 patents)

5. Eiichi Mizohata (3 out of 3 patents)

6. Tomohiro Meshizuka (3 out of 3 patents)

7. Yohei Shimizu (3 out of 13 patents)

8. Hirofumi Doi (3 out of 16 patents)

9. Tatsuya Kawato (3 out of 3 patents)

10. Mari Takatsu (2 out of 2 patents)

11. Noriaki Takasu (2 out of 2 patents)

12. Masanobu Tsukagoshi (2 out of 2 patents)

13. Kenzo Yamatsugu (1 out of 4 patents)

14. Shinichi Banba (1 out of 19 patents)

15. Tsuneji Suzuki (1 out of 24 patents)

6 patents: Sort by Forward Citations

1. 12115223 - Conjugate of biotin-modified dimer and phthalocyanine dye (2024-10-15),

2. 11866457 - Clearing agent (2024-01-09),

3. 11442066 - Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein (2022-09-13),

4. 11286285 - Modified biotin, streptavidin mutant, and usage of them (2022-03-29),

5. 11161884 - Modified biotin, streptavidin mutant, and usage of them (2021-11-02),

6. 9670255 - Modified biotin, mutant streptavidin, and use thereof (2017-06-06),

Savid Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for various medical conditions. With a strong emphasis on research and development, Savid Therapeutics is dedicated to advancing healthcare with cutting-edge solutions. Their team of experts is committed to improving patient outcomes and quality of life through groundbreaking treatments. Visit their website to learn more about their pioneering work in the field of therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#2,219 in Tokyo

#5,851 in Japan

Tokyo, Japan

Savid Therapeutics Inc.